Medicenna Therapeutics is a clinical-stage immunotherapy company developing novel highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Cytokines (ECs). Their mission is to become the leader in the development and commercialization of targeted ECs and Superkines for the treatment of a broad range of cancers and immune-mediated diseases.

Biotechnology

Medicenna Therapeutics

Medicenna Therapeutics' headquarters in Toronto, Canada

Fahar Merchant

Aanchal Sharma, PhD

Rosemina Merchant

Chandra Panchal

Albert G. Beraldo

Karen Dawes

John Geltosky

John H. Sampson

Description

People (2)

Manjunatha Ankathatti Munegowda, DVM, MS, PhD, mMBA

Hardeep Kataria

Jobs